Colgate-Palmolive Company (CL) Position Boosted by Cliftonlarsonallen Wealth Advisors LLC
Cliftonlarsonallen Wealth Advisors LLC increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,358 shares of the company’s stock after buying an additional 408 shares during the quarter. Cliftonlarsonallen Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $916,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. TIAA CREF Investment Management LLC increased its stake in Colgate-Palmolive by 84.2% during the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock worth $333,380,000 after acquiring an additional 2,082,262 shares during the last quarter. Swiss National Bank increased its stake in Colgate-Palmolive by 22.2% during the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock worth $268,393,000 after acquiring an additional 666,400 shares during the last quarter. British Airways Pensions Investment Management Ltd acquired a new stake in Colgate-Palmolive during the second quarter worth about $34,347,000. Karp Capital Management Corp increased its stake in Colgate-Palmolive by 3,749.4% during the first quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock worth $27,901,000 after acquiring an additional 371,307 shares during the last quarter. Finally, Teachers Advisors LLC increased its stake in Colgate-Palmolive by 25.4% during the first quarter. Teachers Advisors LLC now owns 1,814,250 shares of the company’s stock worth $132,785,000 after acquiring an additional 367,977 shares during the last quarter. Hedge funds and other institutional investors own 73.10% of the company’s stock.
In other Colgate-Palmolive news, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Dennis J. Hickey sold 73,872 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the sale, the chief financial officer now directly owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The disclosure for this sale can be found here. Insiders sold 217,969 shares of company stock valued at $15,693,933 in the last ninety days. Insiders own 1.02% of the company’s stock.
Shares of Colgate-Palmolive Company (NYSE CL) opened at 72.72 on Friday. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The firm has a market cap of $64.05 billion, a price-to-earnings ratio of 27.02 and a beta of 0.81. The stock has a 50 day moving average price of $71.99 and a 200-day moving average price of $73.17.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the previous year, the firm earned $0.70 earnings per share. The business’s quarterly revenue was down .5% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/10/08/colgate-palmolive-company-cl-position-boosted-by-cliftonlarsonallen-wealth-advisors-llc.html.
Several equities research analysts have commented on CL shares. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Jefferies Group LLC restated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. Macquarie started coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They set a “neutral” rating and a $76.00 price target for the company. Finally, Royal Bank Of Canada restated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research note on Friday, June 30th. One investment analyst has rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $76.31.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.